Global Fondaparinux Market Industry Outlook 2024–2030: Growth Trends, Competitive Landscape, and Future Opportunities
Abstract
The global Fondaparinux market is witnessing steady growth, driven by the rising prevalence of thromboembolic disorders, an aging global population, and increasing surgical procedures worldwide. Valued at USD 0.82 billion in 2024, the market is projected to reach USD 1.22 billion by 2030, growing at a CAGR of 6.91% from 2025 to 2030.
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 7 January 2026